Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Fortress Biotech Inc (FBIO)

Fortress Biotech Inc (FBIO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 138,729
  • Shares Outstanding, K 70,780
  • Annual Sales, $ 26,880 K
  • Annual Income, $ -84,150 K
  • 60-Month Beta 2.33
  • Price/Sales 5.13
  • Price/Cash Flow N/A
  • Price/Book 1.80

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate -0.32
  • Number of Estimates 3
  • High Estimate -0.26
  • Low Estimate -0.43
  • Prior Year N/A
  • Growth Rate Est. (year over year) -100.03%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.56 +25.64%
on 11/14/19
2.24 -12.50%
on 12/05/19
+0.34 (+20.99%)
since 11/13/19
3-Month
1.20 +63.33%
on 10/14/19
2.24 -12.50%
on 12/05/19
+0.10 (+5.38%)
since 09/13/19
52-Week
0.49 +300.00%
on 12/21/18
2.59 -24.32%
on 02/04/19
+0.94 (+92.16%)
since 12/13/18

Most Recent Stories

More News
Avenue Therapeutics Announces Submission of New Drug Application for IV Tramadol

Avenue Therapeutics, Inc. (NASDAQ: ATXI) ("Avenue"), a company focused on the development of intravenous ("IV") tramadol for the U.S. market, today announced that it has submitted a New Drug Application...

ATXI : 7.50 (+4.75%)
FBIO : 1.96 (+0.51%)
Mustang Bio Announces Updated Clinical Data on MB-107 Lentiviral Gene Therapy for Patients with X-Linked Severe Combined Immunodeficiency

MB-107 preceded by low-dose busulfan conditioning continues to be well tolerated and results in development of functional immune system in newly diagnosed infants with XSCID

MBIO : 3.08 (+0.33%)
FBIO : 1.96 (+0.51%)
Mustang Bio to Participate in the Evercore ISI 2nd Annual HealthCONx Conference

Mustang Bio, Inc. ("Mustang") (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapies into potential cures for hematologic...

MBIO : 3.08 (+0.33%)
FBIO : 1.96 (+0.51%)
Fortress Biotech to Participate in December 2019 Investor Conferences

Fortress Biotech, Inc. (NASDAQ: FBIO) ("Fortress"), an innovative biopharmaceutical company focused on identifying, in-licensing and developing high-potential marketed and development-stage drugs and drug...

FBIO : 1.96 (+0.51%)
Fortress Biotech Announces Pricing of Series A Preferred Stock Offering

Fortress Biotech, Inc. (Common Stock: Nasdaq: FBIO) (Preferred Stock: Nasdaq: FBIOP) ("Fortress"), an innovative biopharmaceutical company focused on identifying, in-licensing and developing high-potential...

FBIO : 1.96 (+0.51%)
Checkpoint Therapeutics Announces Pricing of Public Offering of Common Stock

Checkpoint Therapeutics, Inc. ("Checkpoint") (NASDAQ: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced the pricing of its previously announced underwritten public offering....

CKPT : 1.27 (unch)
NHLD : 2.62 (+1.95%)
FBIO : 1.96 (+0.51%)
Checkpoint Therapeutics Announces Proposed Public Offering of Common Stock

Checkpoint Therapeutics, Inc. ("Checkpoint") (NASDAQ: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced that it is proposing to offer and sell, subject to market conditions,...

CKPT : 1.27 (unch)
NHLD : 2.62 (+1.95%)
FBIO : 1.96 (+0.51%)
Fortress Biotech Ranked in Top 10 of Deloitte's 2019 Technology Fast 500(TM)

Fortress Biotech, Inc. (Nasdaq: FBIO) ("Fortress"), an innovative biopharmaceutical company focused on identifying, in-licensing and developing high-potential marketed and development-stage drugs and drug...

FBIO : 1.96 (+0.51%)
Fortress Biotech: 3Q Earnings Snapshot

NEW YORK (AP) _ Fortress Biotech Inc. (FBIO) on Tuesday reported a loss of $12.8 million in its third quarter.

FBIO : 1.96 (+0.51%)
Mustang Bio Reports Third Quarter 2019 Financial Results and Recent Corporate Highlights

Mustang Bio, Inc. ("Mustang") (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapies into potential cures for hematologic...

MBIO : 3.08 (+0.33%)
FBIO : 1.96 (+0.51%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Strengthening short term outlook on maintaining the current direction.

See More Share

Trade FBIO with:

Business Summary

Fortress Biotech, Inc. is a biopharmaceutical company. The company is engaged in acquiring, developing and commercializing novel pharmaceutical and biotechnology products. Fortress Biotech, Inc., formerly known as Coronado Biosciences, Inc., is based in NEW YORK, United States.

See More

Key Turning Points

2nd Resistance Point 2.11
1st Resistance Point 2.03
Last Price 1.96
1st Support Level 1.91
2nd Support Level 1.86

See More

52-Week High 2.59
Last Price 1.96
Fibonacci 61.8% 1.79
Fibonacci 50% 1.54
Fibonacci 38.2% 1.29
52-Week Low 0.49

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar